S-1/A: Buda Juice Launches IPO to Fund UltraFresh Juice Expansion

Buda Juice, a pioneer in the UltraFresh™ juice category, is launching its initial public offering to raise capital for national expansion and strengthen its cold-chain distribution network.

Summary

• Buda Juice, Inc. is offering 2,666,667 shares of common stock in its initial public offering (IPO), with an estimated price range of $7.50 to $9.00 per share.
• The company plans to list its common stock on the NYSE American under the symbol BUDA, with the closing of the offering contingent upon successful listing.
• Proceeds from the IPO, estimated at approximately $18.08 million (or $20.87 million if the over-allotment option is fully exercised), will be used to develop new production plants in South Carolina and Arizona/Nevada, expand the existing Texas plant, and for general corporate purposes.
• A significant portion, $3,750,000, will be used to redeem 500,000 shares of common stock from co-founder and CEO, Horatio Lonsdale-Hands.
• Buda Juice reported net sales of $11.27 million in 2024, a 20.2% increase from $9.38 million in 2023, and $9.71 million for the nine months ended September 30, 2025, up 14.3% from the same period in 2024.
• Net income for 2024 was $3.57 million (32% margin), a 58% increase from $2.26 million in 2023, and $2.86 million for the nine months ended September 30, 2025, a 9.5% increase from the same period in 2024.
• The company maintains a continuous 35°F cold chain from fruit to shelf, delivering products with an 8-12 day shelf life without heat treatment, HPP, or UV processing.
• Buda Juice is an emerging growth company and a smaller reporting company, electing to comply with certain reduced public company reporting requirements.
• A single customer accounted for approximately 97% of net sales for the nine months ended September 30, 2025, and 95% and 90% for the years ended December 31, 2024 and 2023, respectively, highlighting significant customer concentration risk.
• The company has a three-facility hub model strategy, with the Dallas plant serving the South Central U.S., a planned South Carolina facility (2026) for the Southeast/Mid-Atlantic, and an Arizona/Nevada facility (2027) for the Western U.S.

Sentiment

Score: 7

Explanation: The company demonstrates strong historical financial growth and a clear strategic vision for expansion, backed by a differentiated product and business model. However, significant customer concentration and the inherent risks of an IPO, including dilution and market volatility, temper the overall positive outlook.

Positives

• Strong revenue growth, with net sales increasing from $5.6 million in 2022 to $11.2 million in 2024, representing a 41.8% CAGR.
• Consistent profitability, with net income growing from $2.26 million in 2023 to $3.57 million in 2024, and $2.86 million for the nine months ended September 30, 2025.
• High gross margins, reaching 46% in 2024, demonstrating efficient production and pricing power.
• Pioneering the 'UltraFresh™' juice category with a unique cold-crafted, never heat-treated, never HPP-processed, always cold approach, offering a competitive advantage in taste and nutrition.
• Asset-light business model with outsourced logistics provides operational flexibility and capital efficiency.
• Established long-term relationships with citrus growers ensure consistent premium fruit supply at competitive prices.
• Executive team possesses decades of experience and established relationships with major U.S. grocery retailers, facilitating distribution expansion.
• Strategic retail model offers a comprehensive solution to retailers, eliminating their need for in-store juicing infrastructure and operational complexity.
• Successful diversification efforts initiated with a new national retailer, reducing long-term customer concentration risk.

Negatives

• High customer concentration, with one customer accounting for approximately 97% of net sales for the nine months ended September 30, 2025, posing a significant risk if this relationship deteriorates.
• Limited operating history in new and evolving markets, making future prospects and growth outside the current region difficult to evaluate.
• Reliance on a limited number of cold chain-dependent production and distribution facilities, making operations vulnerable to disruptions.
• Dependence on a limited number of suppliers for raw materials, with some suppliers accounting for over 10% of purchases, creating supply chain risk.
• The IPO includes a $3,750,000 redemption of 500,000 shares from the CEO, reducing the net proceeds available for company expansion and working capital.
• Immediate and substantial dilution for new investors, with the IPO price of $7.50 per share being significantly higher than the pro forma net tangible book value of $1.58 per share after the offering.
• The company does not intend to pay dividends, meaning investor returns depend solely on stock price appreciation.

Risks

• Limited operating history in new and evolving markets makes it difficult to evaluate current business and future prospects.
• Historical financial and operating results may not be indicative of future performance, and the company may not sustain historical profitability levels.
• Operating in a highly competitive beverage industry against larger, better-capitalized competitors.
• Success depends on the continued strength of the brand and consumer perception of product quality, safety, freshness, and healthfulness.
• Future growth depends on the successful development and acceptance of new products and product innovation.
• Reliance on a limited number of cold chain-dependent production and distribution facilities, with any disruption materially affecting operations.
• Business model depends on maintaining strict cold chain logistics from sourcing through delivery, adding complexity, cost, and vulnerability.
• Dependence on the availability, cost, and quality of fresh citrus and other raw ingredients, with agricultural or climate-related disruptions adversely affecting supply and margins.
• Production facilities must maintain compliance with rigorous food safety and regulatory standards; any lapse or contamination could result in recalls, liability, or reputational harm.
• Risks associated with managing short shelf-life products, increasing exposure to inventory spoilage, write-downs, and stockouts.
• Changes in consumer preferences, particularly away from fresh juice, citrus beverages, or premium-priced fresh products, could adversely affect demand.
• Growth strategy depends on geographic expansion, which requires securing and equipping new facilities and may be costly and complex.
• High reliance on a single customer (97% of net sales for the nine months ended September 30, 2025); loss or reduction of purchases would materially affect the business.
• Dependence on a limited number of suppliers for products; loss of one or more could disrupt operations or increase costs.
• Growth depends on expanding distribution through new retail relationships and deeper penetration with existing accounts; failure to secure or maintain these relationships may limit revenue potential.
• Heavy reliance on third-party retailers and brokers to market and sell products; their prioritization, execution, or financial health may directly impact performance.
• High-tech driven, centralized production systems are core to efficiency and quality; technical failures or cybersecurity incidents could disrupt operations or result in data loss.
• Reliance on third-party logistics providers for product delivery; any breakdown or delay could damage product integrity and customer trust.
• Difficulties in forecasting demand accurately could lead to excess inventory, underproduction, missed revenue opportunities, or higher working capital needs.
• Failure to effectively manage growth, including geographic expansion and increased retail distribution, could negatively impact operations and customer experience.
• Potential legal challenges related to the accuracy of health and wellness claims.
• Future success depends on the ability to attract, retain, and develop key employees and senior leadership.
• May require additional capital to support growth strategy or operations, and such financing may not be available on acceptable terms or at all.
• Disruptions in the worldwide economy may adversely affect business, financial condition, results of operations, and cash flows.
• Climate change, or legal or market measures to address climate change, may negatively affect business and operations.
• Fluctuations in business conditions may unexpectedly impact reported results of operations and financial condition.
• Insurance may not provide adequate levels of coverage against claims or protect from all risks.
• Members of management team have limited experience operating a public company, and regulatory compliance may divert their attention.
• Increased costs as a result of operating as a public company, requiring substantial management time for compliance initiatives.
• Food safety and food-borne illness incidents or other safety concerns may materially adversely affect the business.
• Failure to comply with federal and state laws and regulations relating to data privacy, data protection, advertising, and consumer protection.
• Litigation or legal proceedings could expose the company to significant liabilities and negatively impact reputation or business.
• Legislative or regulatory changes that affect products, including new taxes, could reduce demand or increase costs.
• Failure to comply with requirements to design, implement, and maintain effective internal controls could have a material adverse effect on business and stock price.
• Inability to adequately protect intellectual property or facing claims of infringing others' intellectual property.
• No prior public market for common stock; an active market may not develop or be sustainable.
• Price of common stock may be volatile, and purchasers could incur substantial losses.
• A substantial portion of total issued and outstanding shares may be sold into the market at any time, causing stock price to drop.
• If listing application for common stock is not approved by NYSE American, the offering will be terminated.
• Authorization to issue blank check preferred stock without stockholder approval could adversely impact rights of common stock holders.
• As an emerging growth company, the company will not be required to comply with certain reporting requirements, potentially making stock less attractive.
• Broad discretion in the use of net proceeds from the offering, which may not be used effectively.
• Delaware law and provisions in certificate of incorporation and bylaws could make a merger, tender offer, or proxy contest more difficult.

Future Outlook

Buda Juice plans a disciplined, infrastructure-led geographic expansion strategy with two new production facilities in South Carolina (2026) and Arizona/Nevada (2027) to serve a large percentage of the U.S. population. The company aims to expand its multi-channel sales approach, including regional and national broker networks, and increase marketing investment to build brand awareness for its branded products while continuing its successful private label offerings. It also sees untapped opportunities in complementary channels like restaurants, bars, hotels, and institutional food service.

Management Comments

• "At Buda Juice, we started small—one RAW.ORGANIC.REAL. sip at a time. As life became busier, convenience often meant sacrificing health. Recognizing this challenge, we set out to offer delicious, genuinely fresh juices, making it effortless for people to incorporate more fruits and vegetables into their daily lives."
• "While fresh is trending, many retailers often fall short on this promise. Our food system has become so processed that fresh frequently is not fresh at all."
• "Buda Juice is pioneering a new category in beverages, UltraFresh™ juice, offering cold-crafted citrus-based drinks that are never heat-treated, never HPP-processed and always cold."
• "Looking ahead, we believe our opportunity is brilliant. We are not simply capturing market share—we believe we are expanding the refrigerated juice category itself by helping retailers evolve to the next generation of freshness."
• "Buda exists to redefine what fresh juice means. Our vision is to make UltraFresh™ juice the new standard, providing clean beverages in every grocery store across the U.S., without compromise on safety, taste or nutrients."
• "We have traditionally experienced minimal capital expenditures given our asset-light model. We believe that our operating cash flow, access to credit facilities, and this Offering, will provide us with sufficient capability to support our growth plans."
• "While many companies at our stage and with our growth profile adopt a growth-at-all-cost mindset, we have always been focused on production safety first, profitable, responsible, and sustainable growth."

Industry Context

Buda Juice operates in the substantial U.S. fruit juice market, valued at $55.5 billion in 2024 and projected to reach $77.5 billion by 2033 (3.8% CAGR). The company is uniquely positioned in the underserved 'UltraFresh™' category, bridging the gap between shelf-stable, processed juices and operationally complex in-store juicing. It targets supermarkets and hypermarkets, which account for 60-70% of juice sales. The global lemonade segment, a key focus, is also experiencing significant growth (6.3% CAGR to $16.7 billion by 2034). Buda Juice differentiates itself by avoiding traditional pasteurization, HPP, and UV treatments, which are common among major players like Tropicana, Minute Maid, Suja Juice, and Naked, by maintaining a continuous 35°F cold chain.

Comparison to Industry Standards

• Unlike traditional juice companies such as Tropicana (PepsiCo) and Minute Maid/Simply Orange (Coca-Cola) that rely on heat pasteurization, Buda Juice's UltraFresh™ process avoids heat treatment, HPP, and UV, aiming to preserve superior flavor and nutrients.
• Compared to HPP brands like Suja Juice, Naked, Evolution Fresh, and Bolthouse Farms, Buda Juice claims its cold-crafted method maintains a 'true fresh taste' that HPP processing cannot achieve.
• Buda Juice's centralized production model addresses the operational complexities and high costs (labor, equipment, food safety) that limit in-store fresh-squeezed juice offerings to less than 5% of U.S. grocery stores.
• The company's 8-12 day shelf life, achieved through its 35°F cold chain, is longer than boutique cold-pressed juices (3-5 days) but shorter than heat-processed (60 days to 12 months) or HPP-processed juices (30-90 days), striking a balance for retail distribution and freshness.
• Buda Juice's SQF-certified, high-tech production plant and adherence to FDA safety protocols aim to provide a consistently safe product at scale, differentiating it from potentially inconsistent quality in smaller cold-pressed or in-store operations.

Management Changes

Corporate Governance

Legal Proceedings

• The company is not currently a party to any material legal proceedings.
• Approximately six years ago, the company encountered a third-party opposition from a kombucha company using the name Buddha during its trademark application process in Canada. The application was abandoned as Canadian trademark registration was not deemed necessary for U.S. market development.

Related Party Transactions

• The company's revolving line of credit with Amegy Bank (up to $3,000,000) is supported by personal guarantees from three members of the Board of Directors: Horatio Lonsdale-Hands (CEO), Bryan Herr (Executive Chairman), and Bernard Lucien Nussbaumer (Co-founder and Director). These guarantees were reaffirmed as part of the July 9, 2025 amendment.
• A portion of the IPO proceeds, $3,750,000, will be used to redeem 500,000 shares of common stock held by Horatio Lonsdale-Hands, the co-founder and Chief Executive Officer.
• Karina Farquharson, Vice President of Marketing & Data Analytics, is the wife of the CEO, Horatio Lonsdale-Hands.

Stakeholder Impact

• **Shareholders:** New investors will experience immediate and substantial dilution. Existing shareholders, particularly the CEO and co-founders, will maintain significant influence over corporate matters due to concentrated ownership. The IPO aims to provide liquidity and capital for growth, potentially increasing long-term shareholder value, but also introduces public company costs and market volatility.
• **Employees:** The company intends to adopt a 2025 Equity Incentive Plan with a 15% option pool to attract, motivate, and retain employees, aligning their interests with long-term success. Clint Bowers is appointed as CFO nominee, and Karina Farquharson (wife of CEO) is VP of Marketing.
• **Customers (Retailers):** The expansion strategy with new regional plants aims to improve service, reduce logistics costs, and enhance product freshness and shelf life for retail partners. The 'UltraFresh™' model offers a turnkey solution, reducing operational burden for retailers. However, high customer concentration with one major customer poses a risk if that relationship changes.
• **Suppliers:** Long-term relationships with citrus growers are crucial for consistent supply and competitive pricing. Geographic diversification of sourcing (California, Arizona, Mexico) aims to mitigate seasonality and supply chain risks. However, reliance on a limited number of key suppliers remains a risk.
• **Creditors:** The company has repaid its line of credit and has no outstanding debt as of September 30, 2025, improving its credit profile. However, future debt financing may incur significant interest obligations and restrictive covenants.

Next Steps

• Complete the Initial Public Offering (IPO) and successfully list common stock on the NYSE American under the symbol BUDA.
• Develop and furnish a new production plant in South Carolina, projected to be completed in 2026, to serve the East Coast.
• Develop and furnish a new production facility in Arizona/Nevada, projected to be completed in 2027, to serve the West Coast.
• Expand sales and distribution through a multi-channel approach, including regional and national broker networks and leveraging leadership's industry relationships.
• Increase marketing investment to build brand awareness and drive consumer purchasing for branded products.
• Develop dedicated sales resources to pursue opportunities in complementary channels such as restaurants, bars, hotels, and institutional food service.
• Adopt the Buda Juice, Inc. 2025 Equity Incentive Plan upon listing on NYSE American, subject to stockholder approval.
• Implement a clawback policy that complies with Rule 10D-1 under the Exchange Act and NYSE American listing standards.
• Enter into separate indemnification agreements with each director and executive officer prior to the consummation of the offering.

Key Dates

Recommendation

While Buda Juice exhibits impressive historical growth, a differentiated product, and a clear expansion strategy, the significant customer concentration (97% from one customer) presents a substantial risk that a seasoned investor cannot ignore. The IPO proceeds are partially used for a CEO stock redemption, and new investors face immediate dilution. The company's success hinges on its ability to diversify its customer base and execute its ambitious geographic expansion without major operational or competitive setbacks. Given these factors, a 'hold' recommendation is appropriate, suggesting investors monitor the company's progress in customer diversification and expansion execution before making further investment decisions.

Keywords

UltraFresh Juice, Cold-Crafted Beverages, SEC Filing, IPO, Beverage Industry, Food and Beverage, Cold Chain Logistics, Retail Distribution, Juice HACCP, SQF Certified, Organic Juice, Private Label, Geographic Expansion, NYSE American, S-1/A